CEO John C.M. Farquhar sold 22.6K shares of HTFL at $28.50 under pre-arranged 10b5-1 plan; stock now $33.24
John C.M. Farquhar, CEO of Heartflow Inc., sold 22,562 shares at $28.50 on 2026-06-10 under a 10b5-1 trading plan adopted on 2025-09-12, reducing his holdings from 519,397 shares to 496,835 shares. The transaction was scheduled rather than discretionary. The stock currently trades at $33.24, above the sale price, and has posted a 90-day gain of +62.2%, though the CEO's prior same-ticker sales (three trades at HTFL) showed mixed 30-day outcomes ranging from -24.3% to +10.4%. The company remains unprofitable with net income of $-27.4M on quarterly revenue of $52.6M, though it demonstrated +39.9% annual revenue growth, providing limited visibility into valuation sustainability.
CEO Farquhar sells 22,562 shares at $29.12 amid unprofitable operations and mixed prior exit timing.
CEO John Farquhar is selling shares as Heartflow faces a challenging financial backdrop — the company lost over $116 million annually with negative earnings, though revenue is growing briskly. This is the third open-market sale at Heartflow within the past three years for Farquhar, who has yet to purchase shares on the open market as CEO. Farquhar's prior two exits at this company show conflicting timing: at the 30-day mark, one sale proved well-timed (the stock fell afterward) and one was poorly timed (the stock rose); over 90 days, both prior sales were poorly timed as the stock recovered and gained. The current sale occurs as the stock trades notably below its 52-week high, having retreated from a stronger recent period. Without additional cluster context or material events disclosed in the filing itself, this appears to be a routine portfolio management move from the CEO, though the pattern of repeated selling without any offsetting purchases warrants tracking against near-term company catalysts.
CEO Farquhar sold 22,562 shares of HTFL at $26.72; stock now at $29.05 (30-day +41.8%), company unprofitable at -$50.9M net income.
CEO John C.M. Farquhar sold 22,562 shares (22.6K shares) at $26.72 on 2026-04-10, reducing his stake from 571,725 to 549,163 shares (-3.9%). The sale occurred ahead of a significant 30-day rally of +41.8%, meaning the stock price rose substantially after the transaction. Heartflow remains unprofitable with net income of -$50.9M on quarterly revenue of $46.3M, though the company shows strong annual revenue growth of +39.9%. The CEO's prior cross-ticker selling history shows an average 30-day return of -24.3%, and his prior HTFL sale on 2026-02-10 also preceded a -24.3% 30-day decline, but this current sale did not precede a similar downturn—the stock rallied instead. Investors should track whether this represents a one-time portfolio adjustment at the CEO level despite the company's growth trajectory.
CEO John C.M. Farquhar sells 22,562 shares at $27.46; stock -31.6% from 52-week high as HTFL posts $-50.9M net loss on $46.3M revenue
CEO Farquhar sold 22,562 shares at $27.46 on 2026-02-10, reducing his holdings by 3.7% to 591,656 shares. The transaction occurs amid significant stock deterioration: the stock is currently 31.6% below its 52-week high of $39.91 and down 17.6% over the past 30 days. In the latest quarter, Heartflow generated $46.3M in revenue but posted a net loss of $-50.9M, indicating substantial operating challenges. The combination of CEO equity liquidation during a period of depressed valuation and negative earnings suggests material concerns about near-term business trajectory warrant investor scrutiny of upcoming quarterly guidance and cash burn sustainability.
